Guidelines for the Compilation of a Product Dossier for Submission in the Assessment Procedure for New and Multi-Source (Generic) Products Used in the Treatment of Malaria
(11 pages)
Table of Contents
View the documentSection 1. Details of the product
View the documentSection 2. Regulatory situation in other countries
Open this folder and view contentsSection 3. Active pharmaceutical ingredient (s) (API)
Close this folderSection 4. Finished product
View the documentSection 4.1 Formulation
View the documentSection 4.2. Sites of manufacture
View the documentSection 4.3 Manufacturing procedure
View the documentSection 4.4 Specifications for excipients
View the documentSection 4.5 Specifications for the finished product
View the documentSection 4.6 Container/closure system(s) and other packaging
View the documentSection 4.7 Stability testing
View the documentSection 4.8 Container labelling
View the documentSection 4.9 Product information
View the documentSection 4.10 Patient information and package inserts
View the documentSection 4.11 Justification for any differences to the product in the country or countries issuing the submitted WHO-type certificate(s)6
Open this folder and view contentsSection 5. Efficacy and safety
 

Section 4.3 Manufacturing procedure

Provide an outline of the manufacturing procedure for the finished product, including packaging.

Provide a copy of the master formula and a copy of a manufacturing record for a real batch.

For sterile products, details of sterilization processes and /or aseptic procedures used must be described.

A statement of the stages of manufacture at which sampling is carried out for in-process control tests, where other data in the documents supporting the application show such tests to be necessary for the quality control of the medicines

to previous section to next section
 

Last updated: May 3, 2013